Publication | Open Access

SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays

Viral DiagnosticsImmunologyAntiviral TherapyAntibody ScreeningSars-cov-2 Neutralizing AntibodiesChemiluminescent AssaysMedicineCovid-19